167 related articles for article (PubMed ID: 24218408)
21. Histopathologic improvement with lymphedema management, Léogâne, Haiti.
Wilson SF; Guarner J; Valme AL; Louis-Charles J; Jones TL; Addiss DG
Emerg Infect Dis; 2004 Nov; 10(11):1938-46. PubMed ID: 15550203
[TBL] [Abstract][Full Text] [Related]
22. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
Bockarie MJ; Alexander ND; Hyun P; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
Lancet; 1998 Jan; 351(9097):162-8. PubMed ID: 9449870
[TBL] [Abstract][Full Text] [Related]
23. An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
Supali T; Djuardi Y; Christian M; Iskandar E; Alfian R; Maylasari R; Destani Y; Lomiga A; Minggu D; Lew D; Bogus J; Weil GJ; Fischer PU
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009294. PubMed ID: 33780481
[TBL] [Abstract][Full Text] [Related]
24. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.
Cantey PT; Rout J; Rao G; Williamson J; Fox LM
PLoS Negl Trop Dis; 2010 Jun; 4(6):e728. PubMed ID: 20628595
[TBL] [Abstract][Full Text] [Related]
25. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
Wkly Epidemiol Rec; 2004 Oct; 79(40):358-65. PubMed ID: 15631012
[No Abstract] [Full Text] [Related]
26. A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp.
Belizario VY; Amarillo ME; de Leon WU; de los Reyes AE; Bugayong MG; Macatangay BJ
Bull World Health Organ; 2003; 81(1):35-42. PubMed ID: 12640474
[TBL] [Abstract][Full Text] [Related]
27. A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.
Krentel A; Basker N; Beau de Rochars M; Bogus J; Dilliott D; Direny AN; Dubray C; Fischer PU; Ga AL; Goss CW; Hardy M; Howard C; Jambulingam P; King CL; Laman M; Lemoine JF; Mallya S; Robinson LJ; Samuela J; Schechtman KB; Steer AC; Supali T; Tavul L; Weil GJ
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009002. PubMed ID: 33657090
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Assessment of a Hotspot with Persistent Bancroftian Filariasis in Coastal Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Goss CW; Punchihewa MW; Dassanayaka TDM; Ranasinghe USB; Mendis D; Weil GJ
Am J Trop Med Hyg; 2018 Sep; 99(3):735-742. PubMed ID: 30014812
[TBL] [Abstract][Full Text] [Related]
29. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
[TBL] [Abstract][Full Text] [Related]
30. Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb.
Shenoy RK; Suma TK; Rajan K; Kumaraswami V
Ann Trop Med Parasitol; 1998 Jul; 92(5):587-94. PubMed ID: 9797832
[TBL] [Abstract][Full Text] [Related]
31. Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.
Lemoine JF; Desormeaux AM; Monestime F; Fayette CR; Desir L; Direny AN; Carciunoiu S; Miller L; Knipes A; Lammie P; Smith P; Stockton M; Trofimovich L; Bhandari K; Reithinger R; Crowley K; Ottesen E; Baker M
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0004954. PubMed ID: 27706162
[TBL] [Abstract][Full Text] [Related]
32. Residual microfilaraemia in rural pockets of South India after five rounds of DEC plus albendazole administration as part of the LF elimination campaign.
Kalimuthu M; Sunish IP; Nagaraj J; Munirathinam A; Kumar VA; Arunachalam N; White GB; Tyagi BK
J Vector Borne Dis; 2015 Jun; 52(2):182-4. PubMed ID: 26119554
[No Abstract] [Full Text] [Related]
33. Lymphatic pathology in asymptomatic and symptomatic children with Wuchereria bancrofti infection in children from Odisha, India and its reversal with DEC and albendazole treatment.
Kar SK; Dwibedi B; Das BK; Agrawala BK; Ramachandran CP; Horton J
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005631. PubMed ID: 29059186
[TBL] [Abstract][Full Text] [Related]
34. Global programme to eliminate lymphatic filariasis.
World Health Organization
Wkly Epidemiol Rec; 2005 Jun; 80(23):202-12. PubMed ID: 16033148
[No Abstract] [Full Text] [Related]
35. Improving community participation to eliminate lymphatic filariasis in American Samoa.
King JD; Zielinski-Gutierrez E; Pa'au M; Lammie P
Acta Trop; 2011 Sep; 120 Suppl 1():S48-54. PubMed ID: 20932818
[TBL] [Abstract][Full Text] [Related]
36. The role of albendazole in programmes to eliminate lymphatic filariasis.
Ottesen EA; Ismail MM; Horton J
Parasitol Today; 1999 Sep; 15(9):382-6. PubMed ID: 10461168
[TBL] [Abstract][Full Text] [Related]
37. Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia.
Addiss DG; Eberhard ML; Lammie PJ; McNeeley MB; Lee SH; McNeeley DF; Spencer HC
Am J Trop Med Hyg; 1993 Feb; 48(2):178-85. PubMed ID: 8447520
[TBL] [Abstract][Full Text] [Related]
38. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
[TBL] [Abstract][Full Text] [Related]
39. National mass drug administration costs for lymphatic filariasis elimination.
Goldman AS; Guisinger VH; Aikins M; Amarillo ML; Belizario VY; Garshong B; Gyapong J; Kabali C; Kamal HA; Kanjilal S; Kyelem D; Lizardo J; Malecela M; Mubyazi G; Nitièma PA; Ramzy RM; Streit TG; Wallace A; Brady MA; Rheingans R; Ottesen EA; Haddix AC
PLoS Negl Trop Dis; 2007 Oct; 1(1):e67. PubMed ID: 17989784
[TBL] [Abstract][Full Text] [Related]
40. Comparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti.
Mathieu E; Deming M; Lammie PJ; McLaughlin SI; Beach MJ; Deodat DJ; Addiss DG
Trans R Soc Trop Med Hyg; 2003; 97(5):501-5. PubMed ID: 15307410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
